Acucela is focused on the development of novel drugs for the treatment of blinding eye diseases, which we are working to make available to patients as rapidly as possible. Our development decisions are based on rigorous science, a growing body of clinical data that is furthering our understanding of the biology of eye disease and with the counsel of world-renowned experts in ophthalmology.
For specific information about clinical trials of Acucela’s products, please visit clinicaltrials.gov (search for "Acucela"), which offers up-to-date information for locating federally and privately supported clinical trials for a wide range of diseases and conditions.
Focus on Your Vision with Dr. Ryo Kubota
Focus on Your Vision follows Acucela founder Dr. Ryo Kubota’s quest to unlock the science behind new ways to treat dry AMD, dry eye and other eye diseases and restore and protect the vision of countless patients suffering from these conditions. Join the conversation at DrRyo.com as he shares his story, his vision and his knowledge of eye diseases and along the way, highlights the promising treatments of tomorrow.